AMAG Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for AMAG Pharmaceuticals, Inc..The latest application filed is for "methods of reducing risk of preterm birth".

Company Profile

4.15.11

AMAG Pharmaceuticals, Inc. - Waltham MA US
AMAG Pharmaceuticals, Inc. - N/A N/A N/A
AMAG Pharmaceuticals, Inc. - Lexington MA
AMAG PHARMACEUTICALS, INC. -
AMAG Pharmaceuticals, Inc. - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods Of Reducing Risk Of Preterm Birth App 20200188413 - Birch; Robert ; et al.	2020-06-18
Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate Grant 10,556,922 - Mirmehrabi Feb	2020-02-11
Methods of reducing risk of preterm birth Grant 10,471,075 - Birch , et al. Nov	2019-11-12
Polymeric Extended Release Compositions Of Hydroxyprogesterone Caproate And Methods Of Using Same App 20190282588 - Tice; Tom ; et al.	2019-09-19
Crystalline And Amorphous Forms Of 17-alpha-hydroxyprogesterone Caproate App 20180282366 - MIRMEHRABI; Mahmoud	2018-10-04
Methods of reducing risk of preterm birth Grant 9,844,558 - Birch , et al. December 19, 2	2017-12-19
Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Grant 9,555,133 - Groman , et al. January 31, 2	2017-01-31
Macrophage-enhanced Mri (memri) In A Single Imaging Session App 20150297757 - Wolf; Gerald L. ; et al.	2015-10-22
Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Grant 8,926,947 - Groman , et al. January 6, 2	2015-01-06
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents App 20140296509 - Groman; Ernest V. ; et al.	2014-10-02
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents App 20140178310 - Groman; Ernest V. ; et al.	2014-06-26
Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Grant 8,591,864 - MAUSUSGroman , et al. November 26, 2	2013-11-26
Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Grant 8,501,158 - Groman , et al. August 6, 2	2013-08-06
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents App 20130121929 - Groman; Ernest V. ; et al.	2013-05-16
Macrophage-Enhanced MRI (MEMRI) in a Single Imaging Session App 20120003160 - Wolf; Gerald L. ; et al.	2012-01-05
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents App 20110144054 - Groman; Ernest V. ; et al.	2011-06-16
Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Grant 7,871,597 - Groman , et al. January 18, 2	2011-01-18
Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof Grant 7,553,479 - Groman , et al. June 30, 2	2009-06-30
Macrophage-Enhanced MRI (MEMRI) App 20090004113 - Wolf; Gerald L.	2009-01-01

Company Registrations

NCAGE Code	5C9A6	AMAG PHARMACEUTICALS, INC.
CAGE Code	5C9A6	AMAG PHARMACEUTICALS, INC.
S.A.M. Registration	5C9A6 [17511155]	AMAG PHARMACEUTICALS, INC.
SEC	0000792977	AMAG PHARMACEUTICALS, INC. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.